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The cloning and characterization of cDNAs and genes encod-
ing three peroxisome proliferator-activated receptor (PPAR)
isotypes from two species of marine fish, the plaice (Pleu-
ronectes platessa) and the gilthead sea bream (Sparus au-
rata), are reported for the first time. Although differences in
the genomic organization of the fish PPAR genes compared
with their mammalian counterparts are evident, sequence
alignmentsandphylogenetic comparisons showthe fishgenes
to be homologs of mammalian PPAR, PPAR/, and PPAR.
Like their mammalian homologs, fish PPARs bind to a variety
of natural PPAR response elements (PPREs) present in the
promoters of mammalian or piscine genes. In contrast, the
mRNA expression pattern of PPARs in the two fish species
differs from that observed in other vertebrates. Thus, PPAR
is expressed more widely in fish tissues than in mammals,
whereas PPAR and  are expressed similarly in profile to
mammals. Furthermore, nutritional status strongly influ-
ences the expression of all three PPAR isotypes in liver,
whereas it has no effect on PPAR expression in intestinal and
adipose tissues. Fish PPAR and  exhibit an activation pro-
file similar to that of the mammalian PPAR in response to a
variety of activators/ligands, whereas PPAR is not activated
by mammalian PPAR-specific ligands. Amino acid residues
shown to be critical for ligand binding in mammalian PPARs
are not conserved in fish PPAR and therefore, together with
the distinct tissue expression profile of this receptor, suggest
potential differences in the function of PPAR in fish com-
pared with mammals. (Endocrinology 146: 3150–3162, 2005)
PEROXISOME PROLIFERATOR-activated receptors(PPARs) are ligand-inducible transcription factors be-
longing to the nuclear hormone receptor (NHR) superfamily.
To date, three PPAR isotypes have been identified in mam-
mals, birds, and amphibians, termed PPAR, PPAR, and
PPAR or . Each isotype is a product of a separate gene and
each one has a distinct tissue distribution (1–3).
PPARs were originally identified and named as receptors
that are activated by a diverse range of chemicals termed
peroxisome proliferators, previously identified as the agents
responsible for peroxisomal proliferation in rodent liver (4).
Subsequent work has led to the identification of various
natural and synthetic PPAR ligands that include a number of
unsaturated fatty acids, eicosanoids, hypolipidemic agents,
and antidiabetic drugs (5–7). Transcriptional activation of
target genes by PPARs requires the presence of peroxisome
proliferator, or PPAR response elements (PPREs), in the pro-
moter of target genes. PPREs are direct repeat elements of the
DR1 type (direct repeat spaced by 1 bp), and PPARs bind as
heterodimers with the retinoid X receptor on PPREs (8, 9). In
the presence of ligands for both receptors, conformational
changes of the receptors’ ligand binding domain (LBD, or E
domain) result in the release of corepressor proteins, recruit-
ment of coactivator proteins, and subsequent assembly of a
protein complex that enhances transcription of the target
gene (10). A number of PPAR target genes have been char-
acterized to date.Most of these genes are known to have roles
in lipid and glucose metabolism, whereas PPAR ligands are
themselves, inmany cases, the substrates and/or products of
the enzymes whose genes PPARs are known to regulate (11).
Thus, during the last decade PPARs have emerged as critical
regulators of lipid homeostasis in mammals. Due to obvious
medical and pharmacological interest, most studies on
PPARs have concentrated on mammalian genes and pro-
teins, with only sporadic reports about PPARs from other
vertebrates. As far as PPARs from fish species are concerned,
a complete cDNAwith similarity to PPAR has been isolated
fromAtlantic salmon (12) and partial cDNAs for two distinct
PPAR-like proteins have been described from zebrafish
(13). More recently, the bioinformatic analysis of the whole
genome of the pufferfish Fugu rubripes suggested the pres-
ence of single homologs of the human PPAR and  genes
and two homologs of the human PPAR gene in this species
(14). Consequently, the exact number of genes and/or the
presence of distinct PPAR isotypes in fish have not been
determined. In addition, it is not known whether the differ-
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ent PPAR isotypes, if present in fish, act through similar
mechanisms and perform the same critical functions in lipid
metabolism as they do in mammals. Thus, the study of pi-
scine PPARs could provide new insights to PPAR biology,
elucidate the evolution of structure and function of these
receptors, and provide a clearer understanding of the phys-
iological mechanisms which determine lipid and fatty acid
homeostasis in vertebrates.
As a prelude to such studies, we have undertaken a search
for PPAR genes in two species of marine fish, the plaice
(Pleuronectes platessa) and the gilthead sea bream (Sparus
aurata, sea bream herein). We report here the cloning and
characterization of cDNAs and genes encoding for three
PPAR isotypes from each of these fish species.
Materials and Methods
Animals
Wild plaice were caught from the UK coast, and sea bream were
obtained from farmed stock in Greece. Before use, all fish were main-
tained in recirculating sea water and fed ad libitum unless otherwise
indicated. Before sampling, fish were anesthetized and killed by
decapitation.
Experimental animals
National and institutional regulations, in accordance with the Euro-
pean Union’s relevant legislation, have been followed regarding animal
experimentation.
Gene and cDNA isolation
1. Genomic clones. Plaice genomic DNA was prepared by lysis of whole
blood as previously described (15). Sea bream genomic DNA was pre-
pared from muscle tissue with the DNeasy tissue kit (QIAGEN, Hilden,
Germany) according to the manufacturer’s instructions.
The plaice PPAR genes were isolated from a genomic library con-
structed in FIXII (Stratagene, La Jolla, CA), which was screened, at low
stringency [60 C in 20 mm sodium phosphate, 300 mm NaCl (pH 7.7),
7% sodium dodecyl sulfate for hybridization, followed by extensive
washing in 1 standard saline citrate (SSC) at room temperature], with
a DNA probe corresponding to the ligand binding region of a plaice
PPAR cDNA (16). The resulting positive recombinant phages were
subsequently screened with the same probe at higher stringency (65 C
for hybridization followed by washing in 0.1  SSC) before sequence
characterization.
Sea bream partial genomic PPAR clones were isolated by direct PCR
amplification of genomic DNA with the Expand High Fidelity PCR
system (Roche Applied Science, Mannheim, Germany) and primers
based on highly conserved regions of PPARs from other phyla and/or
the plaice PPAR sequences. Thus, primers 5-CCAAAAGAAGAACCG
CAA CAA G and 5-TTG CAG GAG CGG GTG CAA CGA CG, termed
aF and aR, respectively, were used to amplify the PPAR gene. The
PPAR amplicon was obtained with primers 5-ATG GAA TGG TTT
CAGGAAACTGand 5-CTAATACATGTCTTTGTAGATCTCCTG,
termed bF and bR, respectively. For PPAR, three primer pairs, 5-GTC
GAC ATG GTG GAC AC and 5-TGT AAT CCA TGT TCG TCA GG
(g1F and g1R, respectively), 5-GCT GCA AGG GTT TCT TCA G and
5-CGT TGT GTG ACA TGC CG (g2F and g2R, respectively), and 5-
GGG AGC AGT TTA TTA ATT GCA AGC AGC and 5-AAT CTC CGT
CTTCTTCAGCAGCTGGATG (g3F and g3R, respectively), were used
to amplify different segments of the gene. The approximate positions on
the respective genes on which these primers bind are shown in Fig. 1.
All genomic fragments were cloned into the pCR Script vector (Strat-
agene) for further analyses.
2. cDNA clones.Total sea bream liver RNA was reverse transcribed with
the Expand Reverse Transcriptase (Roche). The resulting cDNA was
used as template for rapid amplification of cDNA ends (RACE) PCR for
the amplification of the 5- and 3-ends of the receptors, with primers
derived from partial genomic sequences. Either the SMART (switching
mechanism at 5 end of RNA transcript) RACE kit (BD Biosciences,
Basingstoke, UK) or the 5/3 RACE kit (Roche) were used in these
experiments. For 5-end amplification, the gene-specific primers used
were 5-GCC ACC TCT TTC TCC ACC A, 5-CGG CCC TCT TCT TGG
TCAT, 5-CGACAGTGAAGATCACAGTGATC for PPARs , , and
, respectively. For the 3-end amplification of PPAR, the gene-specific
primer used was 5-CTC TGA TGA ACA AAG ACG GGA. Isolation of
the entire coding sequences of the PPAR isotypes was performed with
RT-PCR on total liver RNA with primers 5-CAT TCC ATG TCT GCC
TTG ATC and 5-TCA GTA CAT GTC CCT GTA GAT TTC TTG C for
PPAR, 5-ATG GAA TGG TTT CAGGAAACT and 5-CTA ATA CAT
GTC TTT GTA GAT CTC CTG for PPAR, and 5-GTC GAC ATG GTG
GAC AC and 5-TAC TCT TGT TAA AGG CTA ATA CAA GTC for
FIG. 1. Sea bream and plaice PPAR gene structures.
Schematic diagram, approximately to scale, for the
structure of the sea bream (S. aurata) and plaice (P.
platessa) PPAR genes. The positions of primers used
to amplify the sea bream genes are indicated. The
exons are shaded according to the corresponding pro-
tein domains that they encode; C andEdomains refer
to the DNA binding and ligand binding domains,
respectively. Alternatively spliced exons and the po-
sitions of initiation and termination codons are in-
dicated. TN indicates a Tc1-like transposon.
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PPAR (initiation and termination codons are underlined). All cDNAs
were cloned into the pCR Script vector (Stratagene) for further analyses.
Plaice cDNAs were isolated by RACE-PCR (SMART cDNA synthesis
kit; BD Biosciences) and primers designed from the predicted coding
regions of plaice PPAR genes. cDNAs were amplified with Pfu poly-
merase (Stratagene) using the SMART RACE anchor primer and the
gene specific reverse primers 5-TTT TAA TAC ACG TCC CGG GTT
TCC, 5-CTG AGC TGA AGA ACA CAT TAT CAT, 5-CTC TAA TAC
AAG TCC TTC ATG for PPAR, , and , respectively. After DNA
synthesis, PPAR sequences were ligated to EcoRV-digested pBlu-
scriptKS (Stratagene) and propagated as plasmid inserts.
Phylogenetic analysis
The LBDs of PPARs from a variety of species were used to perform
phylogenetic analysis.Xenopus, chick, and humanPPAR sequenceswere
obtained from the GenBank/EMBL databases. Fugu, Tetraodon, and ze-
brafish PPAR LBD sequences were obtained by searching the Ensembl
(www.ensembl.org) genomic databases (zebrafish release WTSI Zv4,
September 2004; Fugu release version 2.0, May 2004, Tetraodon release,
September 2004) against plaice PPAR, , and  cDNA sequences using
TBLASTX. LBD sequences were aligned using CLUSTALW (17), includ-
ing the LBD region of human rev-erb (accession no. NM021724) as
an outgroup. Phylogenetic trees were inferred using the Neighbor join-
ing method of Saitou and Nei, 1987 (18), bootstrapped through 1000
iterations to test for robustness and plotted using Njplot
(http://pbil.univ-lyon1.fr/software/njplot.html).
Northern and Southern blot analysis
RNA was isolated from male plaice tissues using TriReagent (Sigma,
Poole, UK), treated with glyoxal and fractionated by agarose gel elec-
trophoresis (15). Gels were blotted to Biodyne B nylon membrane (Pall
Gelman Sciences, Northampton, UK) and hybridized to 32P-deoxy-CTP
(ICN Biochemicals, Basingstoke, UK) labeled probes for the various
plaice PPAR cDNAs. Plaice PPAR probes were derived by PCR from the
5 ends of the PPAR cDNAs using primers directed to the regions
encompassing the translation initiation sites and the boundary of the
first coding exons, thereby producing probes for the regions corre-
sponding to the A/B domains of the PPARs. These fragments were gel
purified, and 25 ng of each were labeled with [-32P]deoxy-CTP by
random priming. The same probes were hybridized to Southern blots
(Biodyne B nylon membrane) of agarose gel-resolved SstI-digested pla-
ice genomic DNA (14). All blots were washed at high stringency (0.1 
SSC, 65 C) before autoradiography.
Riboprobes and ribonuclease (RNase) protection assay
Sea bream PPAR mRNA expression was assessed by the RNase
protection assay using a commercial kit (RNase protection kit; Roche).
For the synthesis of sea bream PPAR isotype-specific riboprobes, the
fragment encoding the D domain of each isotype was amplified by PCR.
For PPAR, primers 5 TTG GAT CCG CCA TTC GGT TTG GTC and
5AGAATT CGC TGAAGT TCT TCA Twere used to amplify a 152-bp
fragment [nucleotides (nt) 571–722 of cDNA]; for PPAR, primers 5
TTG GAT CCG CGA TCC GAT ACG GAC and 5 AGA ATT CGA TGC
TGC GGG CCC T were used to amplify a 177-bp fragment (nt 877-1053
of cDNA); for PPAR, primers 5 TTG GAT CCG CTA TTC GTT TTG
and 5 AGA ATT CCG CGT TAT CTC CGG T were used to amplify a
202-bp fragment (nt 902–1103 of cDNA). For directional cloning into the
pBluescript KS vector (Stratagene), all upstream primers contained a
BamHI restriction enzyme site and all downstream primers an EcoRI site
(underlined in the primer sequences above). A 204-bp -actin fragment
(nt 228–431 of GenBank accession no. AY148350) was amplified by
RT-PCR, from sea bream liver total RNAwith primers 5GACCAACTG
GGA TGA CAT GG and 5 GCA TAC AGG GAC AGC ACA GC and
was cloned into the pCR Script vector (Stratagene). Antisense PPAR
riboprobes were synthesized by T3 RNA polymerase (Promega, Mad-
ison, WI) transcription on the above BamHI-digested plasmids. The
-actin plasmid construct was digested with NotI and the antisense
riboprobe was synthesized by T7 RNA polymerase (Promega) tran-
scription. All riboprobes were labeled with [-32P]CTP (800 Ci/mmol;
Amersham Biosciences Europe, Freiburg, Germany) and their specific
activity was quantified as described in the manual of the RNase pro-
tection kit. Total RNA from sea bream tissues, eggs, and larvae was
extracted with the RNeasy tissue kit (QIAGEN) according to the man-
ufacturer’s instructions. For PPAR expression, 8 g of total RNA from
each tissue sample were hybridized simultaneously with all three iso-
type-specific probes (3 fmol of each) before being subjected to diges-
tion byRNases. For-actin expression, 5g of total RNAwere usedwith
approximately 80,000 cpm of the riboprobe. The protected fragments
were separated on a 6% polyacrylamide gel containing 7m urea. Signals
were visualized by autoradiography andwere quantified either by phos-
phor analysis (Molecular Imager FX system; Bio-Rad, Hercules, CA) or
image analysis (Gel-Pro version 3.0, Media Cybernetics, Silver Spring,
MD). Where applicable, PPAR mRNA expression was normalized to
-actin expression.
Quantitative PCR (Q-PCR)
Total RNA was extracted from sea bream tissues as above and was
quantified fluorometrically. First-strand cDNA was synthesized using
the High-Capacity cDNA Archive Kit (Applied Biosystems, Foster City,
CA) according to themanufacturer’s instructions. Relative abundance of
mRNAs was assessed using the 5 fluorigenic nuclease assay on an ABI
Prism 7000 sequence detector system (Applied Biosystems) using re-
agents of the TaqMan system (Applied Biosystems). The TaqMan probes
for all PPAR isotypes and the reference gene (-tubulin, GenBank ac-
cession no. AY326430)were designed at an exon-intron junction to avoid
detection of DNA contaminants. Primer pairs were designed to amplify
a short amplicon to which the probe, labeled with 6-carboxyfluorescein
(6-FAM) reporter dye at the 5-end and carboxytetramethylrhodamine
(TAMRA) quencher dye at the 3-end, was annealed. Primers for PPAR
were 5-TTC GTGGCTGCCATTATC TG and 5-CAC CAAAGGCAC
ATC CAC C; for PPAR, 5-TGT TTG TTG CTG CCA TCA TTC and
5-TGC TCCACC TGC TTCACG T; for PPAR, 5-GCC TCAATG TCG
GCA TGT and 5-TCC TTC TCC GCC TGG G; for -tubulin 5-CGC
AAA CTG GCT GAC CAG T and 5-CGC TCC ATC AGC AGA GAG
G. TheTaqManprobes for PPAR,, , and-tubulinwere 5-TGCGGA
GAT CGC CCA GGC C, 5-CTG TGG AGA TCG TCC CGG GCT AAT
G, 5-ACA CAA CGC CAT TCG TTT TGG CC, and 5-TCC TTT GGT
GGA GGA ACC GGC TC, respectively. PCRs for all genes were per-
formed by 40 cycles of amplification in a two-step program (95 C de-
naturation step for 15 sec, followed by a 57 C annealing/extension
fluorescence detection step for 30 sec). All samples were run in triplicate
and quantified by normalizing the PPAR signal to that of -tubulin by
the 2Ct method [cycle threshold (Ct) method, ABI Prism 7700 User
Bulletin No. 2].
For plaice, 1 g of total RNA from various tissues was copied to
cDNA with Powerscript reverse transcriptase (BD Biosciences) and 2.5
pmol of oligo-deoxythymidine. Aliquots of these reactions were then
subjected to Q-PCR using a SYBR Green containing PCR mix (ABgene,
Epsom, Surrey, UK) and primers for PPAR, 5-TTCGTCGTCCTTTTA
GCG ACA TGA and 5-TTT CCT GCA CCA GCT GGG CGT GCT; for
PPAR, 5-TAA GAA AGC CCT TCA GTG AGA TCA and 5-TCT TTT
GGA CGA GCA GAG CGT TCT; for PPAR, 5-TCA GGA AAC CTT
TCTGTCAAATGA and 5-GCAGCTGGA TGAGGTGCACGTGGT.
Reactions were run in a two-stage protocol (95 C for 15 sec and 57 C for
30 sec), during which time fluorescence was measured in a Techne
Quantica (Cambridge, UK)Q-PCRmachine. Each samplewasmeasured
in triplicate and sample Ct values were compared with Ct values for
dilutions of purified and quantified cDNA run under identical
conditions.
Production of a fish PPAR antibody
A peptide sequence was employed to generate specific antibodies
against PPAR andwas chosen by analysis ofmultiple alignments of the
deduced plaice and sea bream PPAR protein sequences. The peptide,
NH2-VDTQQLLAWPVGFSLNAVDLSELDDSSHSLC-COOH, was cho-
sen on the basis of its likely specificity for piscine PPAR and is located
in the A/B domain of this isotype. The peptide was synthesized and
keyhole limpet haemocyanin (KLH) conjugated by GENOSPHERE
(Genosphere Biotechnologies, Paris, France). New Zealand rabbits were
immunized with the PPAR peptide by intradermal injection of 1 mg
peptide in Freund’s complete adjuvant at about 40 sites, followed by
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three boostswith 0.5mg peptide atwk 5, 10, and 17. Serumwas collected
after wk 22.
EMSA
Plaice and sea bream PPAR proteins, as well as mouse RXR
(mRXR) (9) were obtained by in vitro transcription and translation
using the TNT coupled reticulocyte lysate system (Promega). EMSAwas
performed as previously described (9). The rat acyl-coenzymeA oxidase
(ACO) and Cyp4A6z probes have been previously described (Refs.
19–21 and references therein). The GSTA1.1–3 probes correspond to the
presumed PPREs of the plaice GSTA1 promoter (15) and specifically
between nt positions 3713–3734 (GSTA1.1), 3718–3740 (GSTA1.2), and
3771–3793 (GSTA1.3) of GenBank accession no. X95199. For antibody-
induced supershifts, 2 l of PPAR antibody or preimmune serumwere
introduced to the reaction mix simultaneously with the proteins and
probe.
Fasting and refeeding experiments
A total of 16 fish (sea bream) were kept unfed for 72 h. At the end of
the fasting period (0 h), three fish were removed and several tissues
(liver, intestine, mesenteral adipose) were obtained for RNA extraction
as described above. The remaining fishwere allowed to feed to satiation.
An additional three fishwere removed at 1, 3, and 24 h after feeding, and
RNA was extracted from the excised tissues for the RNase protection
assay, as described above.
Transfection assays
All plaice and sea bream PPAR cDNAs were cloned into pcDNA3,
verified by sequencing, and prepared for transfection by endotoxin-free
plasmid purification (QIAGEN). Sea bass larval (SBL) cells were main-
tained in DMEMwith 10% fetal bovine serum (FBS). Twenty-four hours
before transfection, cells were harvested by trypsinization, resuspended
inDMEMwith 10% charcoal/dextran-treated FBS (Pierce, Rockford, IL),
diluted as necessary, and distributed to 12-well tissue culture plates (105
cells/well). Cells were transfected 24 h later using, per well, 1 g of
PPRE-reporter plasmid, 0.3 g of PPAR construct, 0.2 g of pCMVgal,
and 7.5 l of Superfect reagent (QIAGEN) according to the transfection
reagent manufacturer’s instructions. The reporter construct consisted of
the mouse Cyp4A6z PPRE linked to the minimal mouse thymidine
kinase promoter placed upstream of a chloramphenicol acetyltrans-
ferase (CAT) gene, as previously described (19). After 4 h, cells were
washed once with PBS and then incubated in 1 ml DMEM with 10%
charcoal/dextran-treated FBS for a further 20 h. Potential activators
were added to each well in 5 l of ethanol and cells harvested 24 h later.
All fatty acids and eicosatetraynoic acid (ETYA) were obtained from
Sigma. Conjugated linoleic acid (CLA)was obtained fromNu-Chek Prep
Inc. (Elysian, MN). Wy-14,643 and rosiglitazone were obtained from
Axxora (Nottingham, UK). CAT expression was quantified by commer-
cial ELISA kit (Roche) and -galactosidase by spectrophotometric en-
zyme assay using o-nitrophenylgalactopyranoside as substrate. After
subtracting mock-transfected backgrounds, results were expressed as
the fold increase in CAT, normalized to -galactosidase, with respect to
the ethanol control. Experimentswere repeated at least twice, andwithin
each experiment all treatments were in triplicate.
Western blot
SBL cellswere transfectedwith plaice and sea breamPPAR constructs
as described above. After 48 h, cells were harvested and total extracts
subjected to SDS-PAGE on 10% polyacrylamide. Gels were then blotted
to nitrocellulose membrane, followed by blocking and incubation with
the PPAR-specific antibody. Cross-reacting protein was visualized by
incubation with anti-Ig-alkaline phosphatase and staining with 5-bro-
mo-4-chloro-3-indolyl phosphate and nitro blue tetrazolium.
Results
Fish PPAR gene structures
Genes for PPARswere isolated from plaice and sea bream
by different methods. Two independent screenings of a pla-
ice genomic library resulted in the isolation of a total of 46
 phage recombinants. Five of these were shown to contain
PPAR-related sequences all from the same locus; two others
containedPPAR-related sequences, also froma single locus,
and two contained PPAR-related sequences from a single
locus. The remaining recombinants contained sequences
with significant similarity to other members of the NHR
superfamily from other species. Sea bream PPAR genes were
isolated by PCRusing primers designed from regions known
to be conserved in PPARs from other phyla. Plaice and sea
bream genomic fragments were selected for further analysis
on the basis that they were likely to encode distinct PPAR
genes, and extensive sequencing revealed three PPAR genes
from each of the fish species (Fig. 1).
The positions of coding exon/intron boundaries in the
plaice and sea bream differed slightly from those of mam-
malian and amphibian PPARs. All mammalian PPAR genes
consist of six coding exons, the last two of which encompass
the LBD. In contrast, in the plaice and sea bream PPAR and
PPAR, the region corresponding to the first exon of the
mammalian LBD is encoded by two exons, whereas in the
plaice and sea bream PPAR is encoded by three exons (Fig.
1). All other piscine coding exon boundaries were in essen-
tially identical positions in fish and mammalian PPAR genes
(Fig. 2). More generally, it is notable that the plaice and sea
bream PPAR genes are up to ten times smaller than their
mammalian counterparts, due to the much smaller introns
present in the fish genes. This is also true of other fish genes
(15) and is indicative of the small size of some fish genomes,
in plaice estimated to be about one fifth the size of the
mammalian genome (22), a situation which greatly facili-
tated the gene first approach to cloning described here. Also
notable is the presence of a Tc1-like transposon upstream of
the first identified exon of the plaice PPAR gene (Fig. 1). The
presence of these transposons in the plaice genome has been
noted previously (15, 23).
To confirm that the isolated genomic sequences encode for
functional gene products, primers were designed and were
used in RACE and RT-PCR experiments with cDNA derived
from liver RNA. Sequence of the amplified products revealed
the presence of the corresponding transcripts. Furthermore,
it confirmed the predicted exon/intron structures of the pla-
ice and sea bream PPAR genes and also demonstrated the
presence of 5 noncoding exons and alternatively spliced
products in the plaice genes (Fig.1). Those from PPAR and
 were located in the genomic clones sequenced, but those
from PPAR were outside of the sequenced portion of the
plaice gene. Both the plaice PPAR and PPARmRNAs exist
as alternatively spliced products based on the fact that prod-
ucts with distinct 5-untranslated regions were obtained
from 5-RACE experiments.
All of the predicted initiation codons conform to typical
Kozak consensus sequences, and in the case of the plaice
PPAR and PPAR these initiation codonswere preceded by
in-frame termination codons. From the positions of potential
translation initiation codons, it is possible that the plaice
PPAR protein could exist in two alternative forms, one
having an N-terminal extension of 20 amino acid residues.
Mammalian PPAR proteins are known to exist in two forms
(PPAR1 and 2) resulting from the use of alternative gene
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FIG. 2. Comparison of PPARs from plaice and sea bream and human PPAR. Alignment of the plaice (pp) and sea bream (sa) PPAR isotypes
with the human (hs) PPAR was generated with ClustalW and identical residues present in four or more of the seven sequences are shaded.
The positions of residues shown to be important in binding the carboxylic head group of the ligand in humanPPARs are indicatedwith an asterisk
below the sequences. Also below the sequences, the positions of exon/intron boundaries common to all PPARs are indicated by an insertion
sign—ˆ; the position of an exon/intron boundary found only in fish species is indicated by the insertion sign in parentheses—(ˆ), and the position
of the exon/intron boundary, which is only present in the fish PPAR genes is indicated by a solid diamond ().
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promoters and splicing (24), although there is no obvious
conservation of sequence between the plaice andmammalian
PPARs in this region. We have not attempted to investigate
whether the plaice PPAR exists in alternative forms, but the
predicted alternative translation initiation codon is a poor
match to the Kozak consensus.
Despite extensive library screening, PCR analysis, and
clone characterization, we have not found more than three
distinct PPAR genes in either plaice or sea bream. However,
it is possible that more than one gene for each PPAR isotype
could exist in some fish species. There are reports of multiple
PPAR genes in zebrafish (13) and for two distinct PPAR
genes in the pufferfish Fugu rubripes (14). Furthermore, we
have found two distinct PPAR genes in Atlantic salmon
(Leaver, M. J., M. T. Ezaz, D. R. Tocher, E. Boukouvala, and
G. Krey, unpublished results). Therefore, to establish
whether additional loci could encode genes with high sim-
ilarity to each of thePPAR geneswe identified,we performed
Southern blots of SstI digested plaice genomic DNA, which
we probed with cDNA portions corresponding to the least
conserved A/B domain of each of the plaice PPARs. This
procedure failed to identify hybridizing fragments other
than those expected from the genomic sequences (Fig. 3).
Similar results were also obtained from sea bream (not
shown), suggesting that each of the identified genes is en-
coded by a single locus. Thus, if additional PPAR genes are
present in the genomes of these two species, these must
diverge substantially at least in the sequence of the A/B
domain.
PPAR sequence comparisons
From the alignment of the deduced amino acid sequence
of the plaice and sea bream PPARs (Fig. 2), it is clear that the
DNA-binding (C) and ligand-binding (E) domains are par-
ticularly conserved among all isotypes from both species.
However, when comparing the same PPAR isotype from the
two species, the sequence similarity extends to the entire
molecule and exceeds 85% identity. In contrast, when com-
pared with PPARs from other vertebrate phyla (e.g. Xenopus
or human) significant identity (70%) is observed only in the
C and E domains with the A/B domain being the least
conserved (30% in PPARs  and  and 15% in PPAR).
Also notable is the reduced identity (65%) in the E domain
between the fish and human or Xenopus PPAR.
Phylogenetic analysis
The LBD sequences of the plaice and sea bream PPARs
were used, along with those of human, chick, and Xenopus
PPARs, and the four identified Fugu PPARs (14), to generate
phylogenetic plots. The plots also included the LBD se-
quences deduced from the four zebrafish PPAR genes iden-
tified on chromosomes 4, 18, 25, and on an as-yet-unplaced
genomic sequence (scaffold zv4-NA15249). An additional
FIG. 4. Neighbor-joining tree for the LBD of PPARs from diverse
species. The deduced amino acid sequences corresponding to the LBD
of the PPAR isotypes from plaice (pp), sea bream (sa), Atlantic salmon
(ss), human (hs), chick (gg), Xenopus (xl), zebrafish (dr), and Fugu (fr)
were used to construct the tree. The tree was rooted to the LBD
sequence of human rev-erbA and was inferred and tested for robust-
ness by bootstrapping. Percentage frequencies with which the tree
topology presented here were replicated after 1000 iterations are
indicated. Main branches corresponding to PPAR, , and  subfam-
ilies are indicated.
FIG. 3. Southern blot of plaice DNA. DNA from three individual pla-
ice was extracted, digested with SstI, resolved by agarose gel elec-
trophoresis and blotted by Southern. Each blot was hybridized with
a probe corresponding to the A/B domain of each plaice PPAR isotype
as indicated, or with a probe corresponding to the plaice PPARDNA
binding domain (PPAR-DNA). The positions of DNA size markers (in
kilobase pairs) are indicated. Note the restriction fragment length
polymorphism (heterozygosity) at the PPAR locus.
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PPAR gene, identified on zebrafish chromosome 11 and re-
lated to PPAR according to sequence comparisons, is as yet
incompletely compiled and was excluded from the phylo-
genetic analysis. Scanning the genome of Tetraodon nigroviri-
dis, the third fish species for which entire genome data are
available, also resulted in the prediction of four PPAR genes.
Specifically, two PPAR-like genes were identified one of
which is located on chromosome 13 and the other on chro-
mosome 19; a single PPAR-like gene was identified on
chromosome 9, and a single PPAR-like gene on chromo-
some 11. These genes exhibited high identity to the corre-
sponding genes from Fugu and thus were not included in our
phylogeny. Instead, four Atlantic salmon LBD regions derived
from distinct genes (Leaver, M. J., M. T. Ezaz, D. R. Tocher, E.
Boukouvala, and G. Krey, unpublished results) were included.
The resulting phylogenetic tree (Fig. 4) shows clear and robust
(based on high bootstrap values for tree topology) clustering of
the sequences into three groups, corresponding to PPAR, ,
and  isotypes. Accordingly, the PPAR from plaice and sea
bream is more closely related to one of the two presumed Fugu
PPAR (frPPAR2 in Fig. 4). Interestingly, the second Fugu
PPAR (frPPAR1) appearsmore closely related to theAtlantic
salmon (ss) PPAR and to the zebrafish PPAR from chromo-
some 25 (drchrom25). The second zebrafish PPAR-like se-
quence, located on chromosome 4 (drchrom4), is somewhat
divergent from the other fish PPAR and indeed is not reliably
placed, basedon lowbootstrapvalues for the tree topology. The
PPAR from plaice and sea bream is also closely related to the
single PPAR from Fugu as well as to PPAR2 from Atlantic
salmon. The second Atlantic salmon PPAR (ssPPAR1) as
well as the two PPAR from zebrafish are more distantly re-
latedwithin this cluster andarenot reliablyplacedbasedon low
bootstrap values. As is the case with PPAR, the plaice and sea
bream PPAR is closely related to the Fugu PPAR.
PPAR isotype expression in sea bream and plaice
The tissue expression profile of each of three sea bream
PPARswas determined by RNase protection and of plaice by
Northern blotting (Fig. 5). For both species, the tissue ex-
pression profile was further confirmed by Q-PCR. In sea
bream, PPAR was the major form expressed in liver and
heart, and PPAR in intestine and adipose tissue. PPAR
transcripts were detected in all sea bream tissues; were more
FIG. 5. Tissue expression profile of sea bream and plaice PPARs. A, RNase protection for expression of sea bream PPARs in different tissues.
L, Liver; K, kidney; I, intestine (proximal to cecum); G, gill; H, heart; S, spleen;W, whitemuscle; R, redmuscle; B, brain; A, adipose (mesenteral).
Each lane contains the RNase-protected fragments from 8 g of total RNA incubated with 3 fmol of radiolabled riboprobes corresponding to
the D domain of each receptor. B, Q-PCR for expression of sea bream PPARs. The graph represents mean and SD of values from triplicate
measurements. Values are arbitrary units relative to the reference (-tubulin). Tissues are as in A. C, Northern blot for expression of plaice
PPARs in different tissues. Each lane contained 5 g of total RNA and replicate blots were hybridized to probes corresponding to the A/B domain
of each plaice PPAR isotype. Tissues are as in panel A. D, Q-PCR for expression of plaice PPARs. The graph represents mean and SD of values
from triplicate measurements. Values are given as copy number relative to total input RNA. Tissues are as in A. The levels of the internal
standards, -actin (panel A) as well as of -tubulin (not shown), for these assays were consistently low in tissues such as the liver and muscle
in both species and bore no relation to the total RNA input. Thus, they could not be used for comparison of PPAR expression in the different
tissues.
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abundant than PPAR in kidney, spleen, and adipose; and
were more abundant than PPAR in the brain. In plaice, the
PPAR expression profile was generally similar to sea bream.
The major differences were the higher level of PPAR over
PPAR in liver and the low level of PPAR in red muscle.
It is of interest to note that, for both species, the -isotype is
expressed in all tissues tested at a level at least equal to that
of PPAR. This is in contrast to both mammals and amphib-
ians where this isotype exhibits a restricted expression pat-
tern, being present mainly in adipose tissue, and only at low
level in most other tissues (3).
To further examine the similarities or differences in the
regulation of PPARmRNA expression in fish andmammals,
the expression of these receptors during sea bream devel-
opment and in response to fasting was determined.
In rodents, as well as in Xenopus, it has been shown that
PPARs are differentially expressed during development (25,
26) and thus, we examined the PPAR expression profile in
fertilized eggs and sea bream larvae of 1, 6, 12, 28, and 50 d
after hatch. As shown in Fig. 6, PPAR transcripts are de-
tectable even in the fertilized eggs, possibly containing also
maternal transcripts and in higher amounts as in d 1 larvae.
In addition, PPAR remains the most abundantly expressed
isotype in the body of sea bream larvae for the developmental
period examined. The early expression of PPARmight sug-
gest that this isotype is involved in themobilization of energy
stored in the yolk sac or other critical functions during early
development, i.e. differentiation, membrane lipids synthesis
and turnover, as these have been proposed for mammals (26,
27). In contrast, PPAR and PPAR expression was only
detectable in larvae some time after d 1, but before d 6, i.e.
within the period that first feeding occurs in this species. This
might indicate a linkwith the regulation of exogenous energy
intake and the progressive differentiation of the organs
where these receptors are mainly expressed. All three iso-
types appear to maintain a constant level of expression after
d 6, although it should be noted that these experiments were
FIG. 6. Expression of PPARs during sea bream development. Total
RNA from sea bream fertilized eggs (Fe) and 1-, 6-, 12-, 28-, and
50-d-old larvae (D1-D50) was subjected to RNase treatment in the
presence of the riboprobes for the three PPARs and -actin (see also
Fig. 5A). Each lane contains the RNase-protected fragments from 5
g of total RNA.
FIG. 7. Effect of nutritional status on PPAR expression in sea bream. A,Upper panel: RNase protection of liver total RNA from sea bream fasted
for 72 h (0), or 1, 3, and 24 h after feeding. Lower panel, Protected signals normalized to -actin (PPAR at point 0 	 1). Average values with
SD of three independent experiments are given. B, As in panel A but using total intestinal RNA as input. Average values of two independent
experiments are given.
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conducted on whole larvae and no information on tissue-
specific expression during these stages is available.
Several recent reports havedemonstrated the effect of fasting
on PPAR expression inmammalian tissues (3, 28, 29). Thus, the
degree to which fish PPARs respond to nutritional modulation
was also testedbydepriving seabreamof food for 72hand then
allowing feeding to satiation. Fishwere removed andRNAwas
extracted from liver, intestine and adipose tissue at the end of
the fasting period, and at 1, 3, and 24 h after feeding. PPAR
expressionwas subsequently assessed by RNase protection. As
shown in Fig. 7A, in liver in the fasted state PPAR is the
dominant isotype expressed. At 1 h after feeding, a dramatic
decrease in the mRNA level of both PPAR and  was ob-
served, which was concomitant with an increase in PPAR
mRNA. The mRNA levels for the three PPAR isotypes in liver
gradually returned to approximately initial values at 24 h after
feeding. In contrast to the important changes observed in the
liver, in intestine or adipose tissue (mesenteral) fasting and
refeeding did not influence the sea bream PPAR or  expres-
sion (Fig. 7B anddata not shown). In both adipose and intestine
tissues, PPAR expression was very low and at the limit of
detection of the RNase protection assay (see also Fig. 5A). Thus,
changes in the expression level of this receptor, if any, could not
be calculated.
Binding of fish PPARs to PPREs
The ability of the fish PPARs to recognize and bind to DR1
elements was tested in EMSA with in vitro-translated sea
bream and plaice PPARs and a variety of PPREs (Table 1).
The ACO and the Cyp4A6z elements are well established
PPREs (Ref. 1 and references therein). The GSTA1.1, 1.2, and
1.3 elements correspond to the three DR1-like elements that
have been identified in the promoter of the plaice GSTA1
gene, a gene that has also been shown to be up-regulated by
peroxisome proliferators (15).
The three plaice and sea bream PPARs bound efficiently,
as heterodimers with themRXR, to all PPREs tested (Fig. 8),
with the exception of the GSTA1.3 element on which no
detectable complexes were observed. In addition, this ele-
ment was a poor competitor for the EMSA complexes of the
other elements tested (data not shown). The nonfunctionality
of the GSTA1.3 element in this in vitro assay may be due to
its significant divergence from the DR1 consensus sequence
(Table 1).
In the case of PPAR from both species, the presence of the
receptor in the EMSA complex was further confirmed with
the use of a fish species-specific anti-PPAR antibody thatwe
have developed (Fig. 8C).
Similar EMSA behavior of all PPAR isotypes from both
species was observed when the human RXR (not shown) or
its plaice ortholog (Leaver,M. J., E. Boukouvala, andG. Krey,
unpublished results) were used instead of the mRXR.
Transactivation
The ability of the fish PPARs to activate transcription
was tested in transient expression assays. To ensure effi-
cient interactions of the exogenous PPARs with the en-
dogenous transcriptional apparatus, a cell line from a ma-
rine fish species (SBL) was selected to examine the effects
of a variety of fatty acids and other compounds on PPAR
activity. As shown in Fig. 9, plaice and sea bream PPAR
behaved very similarly and activated transcription in re-
sponse to all fatty acids tested with the exception of stearic
acid. Oleic acid was the most effective naturally occurring
activator of this receptor from both species. Also notable
is the effect of conjugated linoleic acid (mixed isomers),
which was among the most potent PPAR activators in
both species of fish. In plaice, PPARwas poorly activated
by naturally occurring fatty acids. The largest effects were
seen with palmitoleic and oleic acids. In sea bream, the
effects of fatty acids on this receptor mirrored those seen
on plaice PPAR, although activating to a greater extent.
FIG. 8. PPARs from sea bream and plaice bind to various PPREs. A, The PPARs (, , ) from sea bream bind to various PPREs. In vitro-translated
sea bream PPARs and mouse RXR were incubated with the 32P-labeled probes as indicated. Lane C is the unprogrammed reticulocyte lysate. B,
As inPanelAbutusing theplaicePPARs.C,PPAR-specific antibodysupershifts thePPAR/mRXR/GSTA1.2 complex. Invitro-translatedseabream
(lanes 1 and 2) and plaice (lanes 3 and 4) PPARwas incubatedwithmRXR and the 32P-labeledGSTA1.2 probe in the presence of either preimmune
serum (lanes 1 and 3) or PPAR-specific antibody (lanes 2 and 4). Supershifted complexes are indicated by asterisks.
TABLE 1. PPREs used in EMSA
PPRE Sequence
ACO GACC AGGACA A AGGTCA
Cyp4A6z AACT AGGGCA A AGTTGA
GSTA1.1 GTAT TGGTCA A GGGTCA
GSTA1.2 TCAA GGGTCA A AGGTCA
GSTA1.3 TGAG TGGTCA A GGATCA
Consensus AACT AGGNCA A AGGTCA
Alignment of DR1 elements including the 5 flanking sequences.
The consensus PPRE is as defined in Ref. 20, and the half-sites of the
DR1 are underlined.
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Interestingly, in the presence of PPAR from either fish
species, none of the saturated or monounsaturated fatty
acids tested were able to significantly activate transcrip-
tion from the reporter construct used in this assay. How-
ever, the highly unsaturated arachidonic, eicosapentenoic,
and docosahexenoic acids were capable of activating this
isotype, albeit at a low level and only in sea bream.
Of the synthetic compounds tested, the mammalian
PPAR-specific ligand, Wy-16,463, was an efficient and
specific activator of PPAR in both plaice and sea bream.
ETYA was specific and effective for PPAR in plaice and
in sea bream also appeared to have effects on PPAR.
Perfluoroctanoic acid (PFOA) was capable of activating
PPAR in both species, albeit to a lesser extent than most
of the other effectors. However, of all the presumptive
ligands tested, PFOA elicited the highest response from
PPAR. In contrast, rosiglitazone, a specific and high af-
finity mammalian PPAR ligand (Ref. 1 and references
therein), produced only low levels of activation with fish
PPAR. GW1929, a highly effective and specific nonthia-
zolidinedione mammalian PPAR ligand (30), had no ef-
fect on plaice or sea bream PPAR. Identical transactiva-
tion results were obtained when the PPAR was
transfected in a different fish-derived cell line, the Atlantic
salmon AS cell line (not shown), suggesting that the rel-
ative inactivity of the receptor in the SBL cells was not
likely to be due to the lack of essential factors, such as
PPAR-specific coactivators. Furthermore, we excluded
the possibility that PPAR was not expressed in trans-
fected cells by using the fish PPAR-specific antibody.
Cross-reacting protein of the predicted molecular size was
found only in PPAR-transfected cells and not in cells
transfected with PPAR or  or in mock-transfected cells
(Fig. 9C). Thus, we conclude that the absence of activation
FIG. 9. Transactivation of sea bream
and plaice PPARs. A, Sea bass larval
cells were transfected with the expres-
sion vector pcDNA3, alone (cDNA3) or
containing the coding sequences for the
three sea breamPPARs, a CAT reporter
construct containing the Cyp4A6z
PPRE and a -galactosidase expression
plasmid.Cellswere treatedwith 100M
(unless otherwise indicated) palmitic
acid (16-0), palmitoleic acid (16-1), oleic
acid (18-1), linoleic acid (18-2), linolenic
acid (18-3), arachidonic acid (20-4), ei-
cosapentenoic acid (20-5), docosahex-
enoic acid (22-6), mixed isomers of CLA,
Wy-14,643 (WY, 50 M), PFOA, rosigli-
tazone (ROS, 10 M), GW1929 (GW, 10
M) or ETYA (10 M). Results are ex-
pressed as the fold increase in CAT (af-
ter subtraction of mock transfected
background and normalization to -ga-
lactosidase) with respect to the ethanol
control. Figures represent a single ex-
periment out of two repetitions and all
treatments were in triplicate. Error
bars correspond to SD of themean. B, As
in panel A but using the plaice PPARs.
C, PPAR from both sea bream and pla-
ice is expressed in transfected cells. Ly-
sates from SBL cells transfected with
the fish PPARs (, , and ) were re-
solved by SDS-PAGE, blotted, and vi-
sualized with PPAR-specific antibody.
The positions of protein molecular size
markers (in kilodaltons) are indicated.
Only cells transfected with PPAR
show cross-reacting proteins of the pre-
dicted molecular size (60 kDa).
Leaver et al. • Gilthead Sea Bream and Plaice PPARs Endocrinology, July 2005, 146(7):3150–3162 3159
with the mammalian PPAR ligands was due to intrinsic
structural properties of the fish receptor and not due to
inefficient expression of PPAR in transfected cells.
Of interest to note is that basal expression from the re-
porter construct was increased in the presence of all natural
fish PPAR activators and especially of ETYA indicating that
an endogenous factor(s) is active in the SBL cell line. The
activation profile observedwith the compounds tested in the
presence of the three PPAR isotypes and in particular the
specificity of Wy-14,643 for PPAR suggests that this effect
may be exerted through a PPAR homolog.
Discussion
Piscine PPARs
We have isolated PPAR genes and corresponding cDNAs
from plaice and sea bream, the first report of three complete
PPAR isotypes from any fish species. However, whether there
may be other PPAR genes in the genomes of these fish still
remains unclear. Database mining of the Fugu and zebrafish
genomes applied by others (14) and in this work, suggests the
presence ofmore than three PPARs in these species. Thus, Fugu
harbors two distinct PPAR genes and zebrafish two genes for
each of PPAR and PPAR. Furthermore, as previously stated,
we have also identified two distinct PPAR genes in Atlantic
salmon. In contrast, there is presently no evidence ofmore than
one PPAR gene in any fish species.
According to our phylogenetic analysis, it seems likely that
a further PPAR gene may be present in plaice and sea bream
and indeed inAtlantic salmon. This assumption is based on the
fact that the deduced LBD sequence of one of the Fugu PPAR
genes is more closely related to the plaice and sea bream
PPAR. In contrast, the second Fugu PPAR is more related to
a PPAR we have identified from Atlantic salmon and to the
presumed PPAR gene located on the zebrafish chromosome
25. The PPAR gene we identified in plaice and sea bream is
closely related to the unique PPAR gene from Fugu. Fugu,
plaice, and sea bream belong to the same evolutionary line, the
Percomorpha, and it is therefore probable that there is only a
single PPAR gene in these species. In contrast, both zebrafish
and salmon, belonging to the Cyprinformes and Salmoniformes,
respectively, contain twodistinctPPAR genes (Ref. 13 andour
own results), which could have arisen independently within
these two evolutionary lines. A single PPAR gene has also
been identified in the Fugu genome (14) closely related to the
plaice and sea bream PPAR. Apparently, a single PPAR gene
is also present in zebrafish, on chromosome 11. Thus, it appears
that the number of PPAR genes can vary within fish species,
especially concerning the number of PPAR genes. However,
it should be noted that it is not possible with any confidence to
predict entire PPAR sequences from genome data, nor to con-
clude on the functionality of the presumed genes without com-
plete cDNAanalyses. Thus, to date this report on plaice and sea
bream represents the first complete sequence and functional
data for three PPAR isotypes from any fish species. Further-
more, it is clear that in both plaice and sea bream, as well in the
other fish species discussed above, defined homologs of mam-
malian PPAR, , and  exist, suggesting that PPARs diverged
from an ancestral gene before the evolutionary divergence of
fish and mammalian lines.
Structural features of piscine PPARs
Not unexpectedly, in the proteins encoded by the above
genes, the greatest degree of identity among the plaice and sea
bream PPARs with PPARs from other species is found within
the DNAbinding or C-domain.Within the core of this domain,
i.e. the two zinc fingers, piscine PPARs share approximately
90% identical residues with their mammalian counterparts. In
addition, the feature that distinguishes PPARs from the other
members of theNHR, i.e. aD-box of three instead of five amino
acids, is maintained in the fish receptors. Our results have
demonstrated that fish PPARs, like their mammalian ho-
mologs, heterodimerizewith RXR and bind toDR1 elements of
both mammalian and piscine genes indicating that the DNA
binding properties of the C-domain of these receptors are con-
served in the lower vertebrates. Thus, it is likely that PPAR-
dependent transcriptional activation in fish involves very sim-
ilar promoter structural requirements as in mammals.
The LBDs of the fish PPARs also exhibit significant identity
to PPARs from other species, although the LBDs of the fish -
and-isotypesare longerdue toanextra21-aminoacid residues
in sea bream and plaice PPAR and an extra 23- and 35-amino
acid residues in the sea bream and plaice PPAR, respectively.
Interestingly, these residue insertions all occur in an area that,
in the mammalian PPARs, is unique among nuclear receptors
in forming an extrahydrophilic -helix and a loop, together
forming a structure suggested to influence access to the ligand
binding pocket (31–34). In the plaice and sea breamPPAR and
indeed PPAR, this structure might be expected to be consid-
erably larger and more hydrophilic than its mammalian coun-
terpart with possible implications for ligand binding.
When comparing the fish and mammalian PPAR isotypes,
the least conserved region is the A/B domain, which in fish
appears to be considerably longer. In mammals, this domain
has been shown to participate in ligand-independent modula-
tion of PPAR activity via phosphorylation (35) and by binding
coactivator proteins (36). Interestingly, in both PPAR and ,
the net negative charge of this domain observed in the mam-
malian receptors is also conserved in the piscine ones. In the
mammalian PPAR, this domain is only 42 residues long and
negatively charged due to the presence of 13 glutamate resi-
dues. The high content of charged residues (42% of total) and
the net negative charge of this domain are also maintained in
the sea bream  receptor. In contrast, the plaice PPAR A/B
domain, although also rich in charged residues (39% of total),
has a considerably less negative net charge.
Finally, concerning theDdomain, it is interesting tonote that its
length is absolutely conserved among PPAR  and  from differ-
ent phyla (68 and 67 amino acid residues, respectively), whereas
in the-isotype it is one residue shorter in the fish receptorswhen
compared with mammals (67 vs. 68 amino acids).
Functional characterization of the piscine PPARs
Taken together, all our data suggest that the plaice and sea
bream PPAR isotype broadly resembles PPAR from other
vertebrates. The role of PPAR is hypothesized to be primarily
in controlling the reversible induction of -oxidation in specific
tissues as a response to changing energy requirements and
nutritional status. The evidence for this comes most directly
fromrodentswherePPAR-nullmice showdramatic inhibition
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of fatty acid oxidation during fasting (28, 29). Fasting has also
beenshowntoup-regulate theexpressionofPPAR in liverand
intestine of normal animals (3, 28, 29). Mammalian PPAR is
strongly activated by various naturally occurring fatty acids,
and by synthetic compounds (5–7), and these fatty acids and
other compounds can act as bona fide ligands for the receptor
(34). Like its mammalian homolog, plaice and sea bream
PPAR is most highly expressed in tissues with high -oxida-
tion capacity, namely liver, heart, and, in seabream, redmuscle.
Also similar to mammals, the mRNA expression level of
PPAR is increased in the livers of fasted sea bream. Impor-
tantly, the transactivation profile of plaice and sea bream
PPAR is highly similar to that reported for PPAR in mam-
mals (5, 6). Thus, the fishPPAR is stronglyactivatedbya range
of unsaturated fatty acids and by Wy-14,643, a specific mam-
malian PPAR ligand. Also notable is the efficient transactiva-
tion of the fish receptor byCLA, a compound shown to activate
all mammalian PPAR isotypes (37, 38).
Similar to PPAR, PPAR from both plaice and sea bream
share features with mammalian PPAR. In rodents, PPAR
appears to be ubiquitously expressed and often atmuch higher
levels than PPAR or  (3). Similarly, in plaice and sea bream,
PPAR is expressed in all tissues tested and appears to be the
first isotype expressed during development in fish as is also the
case in amphibians and mammals (25, 26, 39).
Moreover, PPAR is also activated by naturally occurring
fatty acids, albeit to a lesser extent than PPAR, a similar sit-
uation to that reported for PPAR from mammals and am-
phibians (5, 19). The wide tissue distribution and broad fatty
acid transactivation potential of PPAR has recently led to the
proposal that this isotype functions as a widespread regulator
of fat burning inmammals (40). Our results with plaice and sea
bream PPARs would support this contention. Notably, how-
ever, and unlike rodents, PPAR expression in sea bream liver
follows a pattern similar to that of PPAR upon fasting and
re-feeding, i.e. it is induced in the fasted state and decreased
following feeding, whereas in rodents is down-regulated in the
fasted state (3). The potential for different mechanisms to reg-
ulate expression of PPAR isotypes in fish and mammals is
further underscored by the fact that neither PPAR nor  ex-
pression in intestine or adipose tissue was affected by nutri-
tional status in sea bream. In contrast, in both mice and rats,
fasting provokes a substantial decrease of PPAR1 and 2 ex-
pression in adipose tissue (3, 41).
Plaice and seabreamPPAR, unlike either PPARorPPAR
from these species, shows significant differences from itsmam-
malian counterpart. PPAR, inmammals, is considered to play
a critical role in fat accumulation particularly in adipocytes, but
also in monocytes in certain conditions (42). Thus, rodent
PPAR is predominantly expressed in adipose tissue, andparts
of the immune system, particularly monocytes and macro-
phages, being expressed to high level in spleen for example (3).
In contrast, the fish species express this isotype in awider range
of tissues than mammals, with similar or greater levels than
PPAR in most tissues. Furthermore, as mentioned above, the
sea bream PPAR, in contrast to mammalian PPAR, is not
under nutritional control in adipocytes. Other differences be-
tween fish and mammalian PPAR are also evident. Saturated
and monounsaturated fatty acids were not effective in PPAR
transactivation experiments, whereas mammalian PPAR is
effectively activated by monounsaturates (6). Also, the highly
selective and potent mammalian PPAR agonists rosiglitazone
and GW1929 (30, 31) were poor or ineffective activators of this
isotype in fish.Thesedifferencesmightbeexplained fromcloser
considerationof the structureof thepiscinePPAR ligandbind-
ing domain. Of the three residues of human PPAR that are
most important for hydrogen-bonding with the acidic head-
group of PPAR ligands, and which are conserved in all mam-
malian, avian, and amphibian PPARs sequenced to date, i.e.
H323, H449, and Y473 (31–34), only the equivalent residue to
H449 is present in the plaice and sea bream PPAR proteins.
The equivalent to H323 is replaced by isoleucine and Y473 by
methionine (Fig. 2). These differences also exist in Atlantic
salmon PPAR and in Fugu (12, 14) and so are unlikely to be
experimental artifacts. Such residue substitutions could signif-
icantly affect the ligand binding characteristics of fish PPAR,
as our results suggest. However, to our knowledge no natural
or artificially introduced substitutions at these positions have
been reported in the mammalian PPAR, and thus the specific
contribution of these residues in ligand binding remains to be
determined. In addition, as discussed above, it is possible that
the structure of peptide regions suggested to be important in
influencing ligand access to the binding pocket may be signif-
icantly different in the piscine PPAR isotype.
As previously argued, we consider it unlikely that fish spe-
cies contain a second PPAR gene corresponding more closely
to the mammalian receptor. Therefore, it is of great interest,
given the critical roles PPAR plays in mammals, that the pi-
scine receptor is so specifically divergent in both expression
pattern and ligand binding. This divergencemay be a reflection
of the significant differences in the physiology of these species.
Inmammals, selective PPAR ligands have beneficial effects on
insulin resistance during type II diabetes, and these effects are
believed to primarily involve direct action on adipocytes to
promote uptake of lipid and thereby to switch glucose utiliza-
tion in distant tissues. In addition, PPAR ligand-treated adi-
pocytes release a number of peptides and proteins that have
modulatory activities on insulin sensitivity in other tissues (42).
In this regard, it is important to note that most marine fish are
inefficient in carbohydrate absorption and incapable of regu-
lating blood glucose levels, displaying an apparent tissue in-
sensitivity to glucose (43, 44).
Fish are the most diverse group of all the vertebrates and
exhibit a bewildering array of life and reproductive strategies,
and it may be that fish species have used PPARs in different
ways to terrestrial vertebrates. Further study of PPAR function
in fish may indicate pathways that are common to critical pro-
cesses inboth fishandmammals, providingadditional focus for
research in important human diseases.
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